Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.

Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.

Abstract: The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.

Abstract: The present invention relates to a vaccine for protecting a pig against diseases associated with corona virus infection including porcine epidemic diarrhea virus (PEDV) and/or porcine deltacorona virus (PDCoV). The vaccine commonly includes inactivated/killed PEDV (e.g., chemically inactivated PED virus), and/or recombinant PEDV antigen, and/or an adjuvant inactivated/killed PDCoV (e.g., chemically inactivated PDCoV virus), and/or recombinant PDCoV antigen and an adjuvant. Methods for protecting pigs against diseases associated with PEDV and/or PDCoV and methods of producing the porcine epidemic diarrhea virus and/or porcine deltacorona virus vaccine are also provided.

Abstract: The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.

Abstract: The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.

Abstract: The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.

Abstract: The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.

Abstract: The invention relates to a holding and packaging device for a tooth implant, with an elongate cylindrical receiving element (12) which has a cylinder wall (14) and at least one end wall (16), wherein the end wall (16) has an opening (18) for receiving a tooth implant (50), and the cylinder wall has a longitudinal opening (20) in this region. It is proposed that the longitudinal opening (20) extends over the entire length of the cylinder wall (14), that at least two grip elements (22, 24) which are mounted opposite each other on the cylinder wall and extend outward are provided, and that the cylinder wall (14) is manufactured from an elastic material such that, by application of a force, the opening (18) in the end wall (16) can be widened in order to introduce or remove a tooth implant.

Abstract: The invention relates to a holding and packaging device for a tooth implant, with an elongate cylindrical receiving element (12) which has a cylinder wall (14) and at least one end wall (16), wherein the end wall (16) has an opening (18) for receiving a tooth implant (50), and the cylinder wall has a longitudinal opening (20) in this region. It is proposed that the longitudinal opening (20) extends over the entire length of the cylinder wall (14), that at least two grip elements (22, 24) which are mounted opposite each other on the cylinder wall and extend outward are provided, and that the cylinder wall (14) is manufactured from an elastic material such that, by application of a force, the opening (18) in the end wall (16) can be widened in order to introduce or remove a tooth implant.

Abstract: The invention relates to a method for production of a zeolite layer on a substrate containing metal, comprising the following method steps: production of an aqueous suspension, comprising several components, one component comprises at least one cross-linking element from the third, fourth or fifth main group of the periodic table, the substrate containing metal comprises at least one of the cross-linking elements, introduction of the substrate containing metal to the aqueous suspension, heating the aqueous suspension and the substrate containing the metal present therein for the in-situ crystallisation of a zeolite layer on the substrate containing metal, whereby the cross-linking elements in the substrate containing metal are extracted and included in the zeolite layer, a cross-linking element present in the suspension for formation of the zeolite layer is present at a concentration so low that a crystallisation in the suspension is largely or completely avoided and said element is principally provided by th